Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0. 4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study - Guidet, B; Martinet, O; Boulain, T (Crit Care, 2012)
et al.